Paris-Sud University

NewHydrogen CEO Steve Hill Discussed Use of Hydrogen for Aviation with University of Tennessee Expert

Retrieved on: 
Martedì, Aprile 9, 2024
Mechanical, Academic Press, Electricity, Paris-Saclay University, Mechanics, Combustion, Associate, National Science Foundation, École Centrale Paris, Airbus, Research, Aviation, University, Carbon, Student, Paris-Sud University, NASA, American Institute, Investment, Society, Hydrogen, Water, Frustration, Doctorate

SANTA CLARITA, Calif., April 09, 2024 (GLOBE NEWSWIRE) -- NewHydrogen, Inc. (OTCMKTS:NEWH), the developer of ThermoLoop™, a breakthrough technology that uses water and heat rather than electricity to produce the world’s cheapest green hydrogen, today announced that in a recent podcast the Company’s CEO Steve Hill spoke with Dr. Paul Palies, Associate Professor at the University of Tennessee Space Institute and founder of the Combustion and Propulsion for Aviation Research Center regarding future aviation based on hydrogen combustion for a decarbonized system.

Key Points: 
  • Dr. Palies said, “There is a need for a clean combustion system that doesn't add nitrogen oxide and completely removes the carbon footprint.
  • Dr. Palies said, “Our team is conducting research on premix combustion, a method that could reduce emissions while maintaining thermal power.
  • Mr. Hill thanked Dr. Palies for his insights, and briefly introduced NewHydrogen’s work on developing thermochemical approaches to affordable green hydrogen.
  • Dr. Paul Palies is Associate Professor at The University of Tennessee Space Institute where he established the Combustion and Propulsion for Aviation Research Center, his research group.

Carmell Corp Announces Addition of Scott Frisch and Gilles Spenlehauer to Board of Directors

Retrieved on: 
Giovedì, Novembre 16, 2023
Rhône-Poulenc, Pharmacy, KPMG, Bank, Head, Peptide, Comptroller, Paris-Sud University, Education minister, AARP, Science, Management, Villanova University, Future, Doctor of Philosophy, Information technology, Bank of America, Putnam Investments, Accounting

PITTSBURGH, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a human biomaterials company (“Carmell”), today announced the addition of two independent directors to their Board.

Key Points: 
  • PITTSBURGH, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a human biomaterials company (“Carmell”), today announced the addition of two independent directors to their Board.
  • Scott Frisch currently serves as Chief Operating Officer and Chief Financial Officer of AARP.
  • AARP is the nation’s largest nonprofit, nonpartisan organization focused on issues affecting the more than 100 million people ages 50 and older.
  • Dr. Gilles Spenlehauer currently serves as Scientific Director of SDTech Group, a chemical manufacturing company.

Aitia Appoints Drug R&D Executive Jean-Michel Gries as President & Chief Operating Officer

Retrieved on: 
Martedì, Settembre 19, 2023
Clinical pharmacology, Analytical chemistry, Drug development, Doctor of Pharmacy, University, Causal AI, Statistics, Roche, MBA, Parexel, Doctor of Philosophy, CNS, Science, Paris-Sud University, Wharton School of the University of Pennsylvania, Novartis, Patient, Ophthalmology, Widener University Commonwealth Law School, Drug discovery, Paris Descartes University, GNS, Digital twin, AI, Pharmacology, ChromeOS, Fine chemical, Alcon, Causality (physics)

SOMERVILLE, Mass., Sept. 19, 2023 /PRNewswire/ -- Aitia, the leader in the development and application of Causal AI and Digital Twins to discover and develop new drugs, today announced the appointment of Dr. Jean-Michel Gries as President & Chief Operating Officer.

Key Points: 
  • SOMERVILLE, Mass., Sept. 19, 2023 /PRNewswire/ -- Aitia, the leader in the development and application of Causal AI and Digital Twins to discover and develop new drugs, today announced the appointment of Dr. Jean-Michel Gries as President & Chief Operating Officer.
  • Jean-Michel is an accomplished senior life science executive with a track record of innovative drug discovery, translational medicine, and clinical development, combining the science and business of drug development.
  • He comes with a wealth of unique experience in drug R&D from big pharma, CROs, and small biotechs.
  • "I look forward to bringing my expertise and working alongside Colin and the teams towards revolutionizing drug discovery and development and ultimately improving the lives of patients."

Senior Computer Vision Leader and Mapping Expert Luc Vincent Joins Hayden AI as its Chief Product & Technology Officer

Retrieved on: 
Martedì, Luglio 11, 2023
Technology, Transport, Software, Construction & Property, Urban Planning, Artificial Intelligence, Public Transport, Lead, Chief technology officer, University, Meta, Google Street View, Paris-Sud University, Geo, Doctor of Philosophy, ParisTech, Harvard University, Toyota, Computer vision, Lyft, Acquisition, Robotics, Physics, City, AI, Computer science, Build automation, École polytechnique, Mobile phone

Hayden AI today announced that Luc Vincent, a former AI leader at Meta, has joined the company as its Chief Product & Technology Officer.

Key Points: 
  • Hayden AI today announced that Luc Vincent, a former AI leader at Meta, has joined the company as its Chief Product & Technology Officer.
  • “We are absolutely thrilled to have Luc on our team,” Chris Carson, CEO and co-founder of Hayden AI, said.
  • Prior to joining Hayden AI, Vincent was VP of Engineering & Product Group Lead at Meta, where he led one of the company's AI Innovation Centers.
  • in Computer Science from University of Paris XI; and a PhD in Computer Vision from MINES ParisTech.

Softonic Appoints Farouk Merzougui as Vice President of Finance and Legal, Strengthening Its Leadership Team

Retrieved on: 
Giovedì, Giugno 15, 2023
Paris-Sud University, Treasury, Knowledge, Growth, FMCG, Software, Management, Security (finance), Softonic.com

Softonic Appoints Farouk Merzougui as Vice President of Finance and Legal, Strengthening Its Leadership Team

Key Points: 
  • Softonic Appoints Farouk Merzougui as Vice President of Finance and Legal, Strengthening Its Leadership Team
    The issuer is solely responsible for the content of this announcement.
  • Softonic Appoints Farouk Merzougui as Vice President of Finance and Legal, Strengthening Its Leadership Team
    Farouk Merzougui brings over 20 years of international experience in accounting, financial planning and analysis, treasury, taxation, legal, and M&A operations.
  • Softonic, a global leader in software and app discovery, is pleased to announce the appointment of Farouk Merzougui as its new Vice President of Finance and Legal.
  • As Vice President of Finance and Legal at Softonic, Mr. Merzougui will leverage his extensive knowledge and strategic thinking to lead the team in developing and implementing innovative financial models.

Chatham Hires Jennifer McLellan as a Managing Director in Global ISDA and Regulatory Practice

Retrieved on: 
Martedì, Giugno 6, 2023
Professional Services, Finance, Consulting, Asset Management, Banking, Accounting, University, LBO valuation model, ISDA, Real estate investment trust, FX, OTC, UCITS, Knowledge, Paris-Sud University, Financial services

Chatham Financial, a global leader in financial risk management advisory and technology solutions, is pleased to announce Jennifer McLellan is joining the company as a Managing Director in the global OTC derivative instruments, ISDA and regulatory practice.

Key Points: 
  • Chatham Financial, a global leader in financial risk management advisory and technology solutions, is pleased to announce Jennifer McLellan is joining the company as a Managing Director in the global OTC derivative instruments, ISDA and regulatory practice.
  • Jennifer established a leading practice in 2011 for law firm Dickson Minto, where she was the Head of Derivatives before joining Chatham.
  • Jennifer brings hands-on knowledge in navigating complicated cross-border M&A leveraged deals, including some of the largest European LBOs.
  • “Chatham is unrivalled in the market for their scale and coverage, and I have personally experienced their first-class approach to client service,” said Jennifer.

CARsgen Appoints Dr. Sylvie Peltier as Senior Vice President of Global Regulatory Affairs

Retrieved on: 
Lunedì, Ottobre 31, 2022
Health law, View, Multimedia, CMC, Therapy, Regulatory affairs, Knowledge, Diploma in Pharmacy, Patient, TEVA, DESS, Cancer, NYSE, Company, Paris-Sud University, Doctor of Pharmacy, University, NASDAQ, Senior, File, CAR, Cephalon, Head, Medical device, Pharmaceutical industry

Dr. Peltier has extensive global leadership and hands-on experiences in clinical and CMC regulatory affairs across several multinational pharmaceutical and biopharmaceutical companies.

Key Points: 
  • Dr. Peltier has extensive global leadership and hands-on experiences in clinical and CMC regulatory affairs across several multinational pharmaceutical and biopharmaceutical companies.
  • Prior to joining CARsgen, Dr. Peltier served as Vice President, Head of US Regulatory Affairs at MorphoSys US Inc (NASDAQ: MOR) since 2020, and as Head of Regulatory Affairs at Servier Pharmaceuticals LLC from 2018.
  • Dr. Raffaele Baffa, Chief Medical Officer of CARsgen Therapeutics, said: "We are delighted to have Dr. Peltier join CARsgen.
  • Dr. Sylvie Peltier, Senior Vice President of Global Regulatory Affairs of CARsgen Therapeutics, said: "CARsgen is a leader in CAR T-cell therapies globally, with competitive product pipelines and technology platforms.

GlycoEra AG Expands Board of Directors and Appoints Georges Gemayel, Ph.D., as Chair

Retrieved on: 
Martedì, Luglio 12, 2022
Genzyme, Biotechnology, Membrane protein, Society, Trustees of Princeton University, National Science Advisory Board for Biosecurity, Director, Doctor of Philosophy, Supervisory board, Princeton University, Infection, Pharmacology, Novartis, Saint Joseph University, Therapy, CEO, Pharmacy, China Biologic Products, Degenerative disease, DRS, Neurology, Board, Allergan, Corporation, Johnson & Johnson, Engineering, University of Pennsylvania Health System, Sofinnova, CHF, Department, Growth, Paris-Sud University, GlaxoSmithKline, Acquisition, Multimedia, SA, Central Waqf Council, Chair, Actelion, Molecular biology, Board of directors, Allergy, Management, Pharmaceutical industry, Prosensa, Takeda, Parmar

SCHLIEREN, Switzerland and BOSTON, July 12, 2022 /PRNewswire/ -- GlycoEra AG announced today key appointments of biotech industry leaders to its Board of Directors, including Georges Gemayel, Ph.D., as Chair, as well as Philippe Dro, Ph.D., M.B.A., and Kush Parmar, M.D., Ph.D. Dr. Gemayel is an industry veteran with more than 30 years' experience including global management, executive positions and a range of board appointments. Dr. Dro is Chairman of the Board and Chief Executive Officer at Luciole Medical and has deep experience in biotech business strategy at various emerging biotechnology and medtech companies. Dr. Parmar is a physician-scientist and Managing Partner at 5AM Ventures, where he is focused on building next-generation life science companies.

Key Points: 
  • "Georges' international biopharmaceutical leadership experience and track record of developing successful medicines will prove invaluable as we build a high-value pipeline of medicines.
  • In addition, both Philippe and Kush bring strategic, business and company building expertise to help guide our trajectory of growth."
  • He was CEO and member of the Supervisory Board at GlycoVaxyn AG prior to its acquisition by GlaxoSmithKline.
  • GlycoEra AG is a biotechnology company building a high-value pipeline of medicines based on deep expertise in glycobiology and protein degradation.

LinKinVax Puts Together a Highly Experienced Team From the World of Biopharmaceuticals to Lead the Clinical Development and Upscaling of Its Vaccine Platform

Retrieved on: 
Giovedì, Maggio 19, 2022
Science, Biotechnology, Research, Pharmaceutical, Oncology, Health, Infectious Diseases, Clinical Trials, Chemistry, GSK, MBA, Knowledge, Health, Kellogg-HKUST Executive MBA Program, R, Public health, Toxicology, Functional presence engine, Infection, CSR, Lists of television programs, Vaccine, COVID-19, Quality control, DESS, Pharmacy, Health care, CMC, Hasna Begum, Engineering, CRO, Paris-Sud University, Technology, Biomarker, Ministry of Education (Malaysia), ESSEC, CMO, HIV, Amgen, Cancer, Neutralizing antibody, Innovation, Pharmaceutical industry, Management, Eurofins Scientific, Audencia Business School, Protein structure

We are delighted to welcome these four experts in healthcare product development.

Key Points: 
  • We are delighted to welcome these four experts in healthcare product development.
  • Their sound knowledge and extensive experience of the biopharmaceuticals industry will provide invaluable support for the various clinical stages of our drug candidates.
  • She has developed and registered drugs on a global scale and acquired in-depth knowledge of sterile injectables.
  • Alexandra holds a doctorate in pharmacy from Paris V University and an Executive MBA in Healthcare Management from IAE Sorbonne Business School.

France Construction Equipment Market Assessment & Forecast Report 2022-2028 Featuring Prominent Vendors - Caterpillar, XCMG, Liebherr, Komatsu, Kubota, Volvo, JCB, SANY, Hitachi, John Deere & Co - ResearchAndMarkets.com

Retrieved on: 
Martedì, Febbraio 1, 2022
Natural Resources, Other Construction & Property, Commercial Building & Real Estate, Construction & Property, Mining, Minerals, Komatsu, Growth, Tungsten, Government, USD, Caterpillar, Gold, JCB, XCMG, University, Volvo Construction Equipment, Climate change, Grand Paris, Campus, Antimony, Hitachi, CAGR, Company, Paris-Sud University, Grand Paris Express, Lifting, John Deere, Volvo, Investment, Industry, Mining, Heavy equipment, Kubota, Liebherr, SANY

The "France Construction Equipment Market - Strategic Assessment & Forecast 2022-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "France Construction Equipment Market - Strategic Assessment & Forecast 2022-2028" report has been added to ResearchAndMarkets.com's offering.
  • Renovation of public infrastructure and government buildings supports earthmoving equipment growth in France's construction equipment market.
  • The preparation for Olympic Games-2024 in Paris and The Grand Paris project driving construction equipment sales.
  • The key players in France construction equipment market are Caterpillar, Liebherr, Komatsu, Kubota, Volvo Construction Equipment, JCB, SANY, Hitachi, John Deere & Company, Xuzhou Construction Machinery Group Co., Ltd. (XCMG)
    In October 2021, Volvo launched Volvo Prototype LX03: The Intelligent Future of Construction.